Transfer of convalescent serum to pregnant mice prevents Zika virus infection and microcephaly in offspring
Transfer of convalescent serum to pregnant mice prevents Zika virus infection and microcephaly in offspring
复制标题
DOI:
10.1038/cr.2016.144
复制
发表时间:
2016-12
期刊:
影响因子:
44.1
通讯作者:
Shuo Wang;Shuai Hong;Yongqiang Deng;Qing Ye;Ling-Zhai Zhao;Fu-chun Zhang;C. Qin;Zhiheng Xu
中科院分区:
文献类型:
--
作者:
Shuo Wang;Shuai Hong;Yongqiang Deng;Qing Ye;Ling-Zhai Zhao;Fu-chun Zhang;C. Qin;Zhiheng Xu
Zika virus (ZIKV) is spreading rapidly around the world in over 60 countries. There is a mounting concern over the association of ZIKV infection and devastating cases of fetal and newborn microcephaly cases [1]. The connection between ZIKV infection and microcephaly was first proposed based on the presence of ZIKV in microcephalic fetal brain tissues [1]. The causal link between ZIKV infection and microcephaly was recently confirmed in animal models and human cerebral organoids [2-4]. The infection is likely to cause deregulation of genes related to neural progenitor cell (NPC) development, cell death and immune response, and subsequently microcephaly [2-4].As a ZIKV vaccine is likely years away, there is an urgent need to explore immediately available therapeutics for effective treatment against ZIKV. Over the past decades, human convalescent plasma derived from patients recovered from diseases has been used in emergency response to emerging viral diseases, such as severe acute respiratory syndrome, H5N1 influenza, Ebola virus disease and Middle East respiratory syndrome [5]. Notably, convalescent plasma is safe for pregnant women and children. Here we describe the effects of treatment with human convalescent serum in an established animal model of microcephaly [2].